Double-Team biopsy could catch more dangerous prostate cancers
NCT ID NCT06579911
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether combining two advanced imaging techniques (micro-ultrasound and MRI) during prostate biopsy can find more aggressive cancers than the current standard approach. About 400 men with suspected prostate cancer will participate. The goal is to improve detection of dangerous cancers while avoiding overdiagnosis of slow-growing ones.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICALLY SIGNIFICANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Uniklinikum Salzburg, Department for Urology and Andrology
RECRUITINGSalzburg, State of Salzburg, 5020, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which biopsy route catches more aggressive prostate cancers?
- AI could spare thousands from unnecessary prostate biopsies
- New scan could slash unnecessary prostate biopsies
- New blood test could spot dangerous prostate cancer without a biopsy
- New scan could help men with Low-Risk prostate cancer avoid unnecessary biopsies